Breast Cancer
75 Articles & Excerpts
Cancer Risk in Ashkenazi Jews
by National Cancer Institute
In 1995, scientists from the National Institutes of Health (NIH) discovered that a particular alteration in the breast cancer gene called BRCA1 was present in 1 percent of the general Jewish population.
Progesterone-Like Drug Controls Hot Flashes
by National Cancer Institute
Hot flashes - increases in body temperature that occur as a result of fluctuating hormone levels - are a common problem for women approaching menopause. Hot flashes also afflict premenopausal women treated with chemotherapy
Preventive Mastectomy
by National Cancer Institute
Preventive mastectomy (also called prophylactic or risk-reducing mastectomy) is the surgical removal of one or both breasts. It is done to prevent or reduce the risk of breast cancer in women who are at high risk of developing the disease.
Paget's Disease of the Nipple
by National Cancer Institute
Paget's disease of the nipple is an uncommon type of cancer that forms in or around the nipple. Paget's disease of the nipple is almost always associated with an underlying breast cancer.
Oral Contraceptives and Cancer
by National Cancer Institute
Some cancers depend on naturally occurring sex hormones for their development and growth. Researchers are interested in learning whether the hormones in oral contraceptives affect cancer risk in women.
Treatment Improves Outlook for Breast Cancer
by National Cancer Institute
Study researchers found that letrozole, when taken after five years of tamoxifen therapy, substantially increased the chance of remaining cancer free. In total, 132 women taking the placebo had their disease recur compared to 75 on letrozole.
Male Breast Cancer Treatment
by National Cancer Institute
Different types of treatment are available for men with breast cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials.
Male Breast Cancer
by National Cancer Institute
Breast cancer may occur in men. Men at any age may develop breast cancer, but it is usually detected (found) in men between 60 and 70 years of age. Male breast cancer makes up less than 1% of all cases of breast cancer.
Probability of Breast Cancer in American Women
by National Cancer Institute
An estimated risk represents the average risk for all women in the United States as a group. This estimate does not indicate the risk for an individual woman because of individual differences in age, family history, reproductive history, race / ethnicity
Letrozole More Effective Than Tamoxifen in Early Breast Cancer
by National Cancer Institute
In this large international trial of postmenopausal women surgically treated for early-stage, hormone responsive breast cancer, letrozole (Femara®) did better to prevent a recurrence of disease (especially distant metastases) than the commonly
Lapatinib Delays HER2 - Positive Breast Cancer
by National Cancer Institute
Between 20 and 25 percent of breast cancers make too much of (overexpress) a protein called HER2, which also is made by normal breast cells. Tumors that overexpress HER2 (called HER2-positive) tend to grow faster and are more likely to come back
Breast Cancer Detection and Diagnosis
by National Cancer Institute
The National Cancer Institute (NCI) is funding numerous research projects to improve conventional mammography (an x-ray technique to visualize the internal structure of the breast) and develop other imaging technologies to detect, diagnose
Herceptin (Trastuzumab)
by National Cancer Institute
What is Herceptin? How does it work? Herceptin (trastuzumab) is a monoclonal antibody. It belongs to a group of drugs made in the laboratory that are designed to attack specific cancer cells.
Genetic Testing for BRCA1 and BRCA2
by National Cancer Institute
Each year, more than 192,000 American women learn they have breast cancer. Approximately 5 to 10 percent of these women have a hereditary form of the disease. Changes, called alterations or mutations, in certain genes make some women more susceptible
Exemestane Boosts Survival in Breast Cancer
by National Cancer Institute
Following surgery for breast cancer, women whose tumors grow in response to the hormone estrogen usually take the anti-estrogen drug tamoxifen for five years to reduce their risk that the disease will recur.
Breast Cancer Risk
by National Cancer Institute
This fact sheet provides information on the Breast Cancer Risk Assessment Tool and about breast cancer risk and the drug tamoxifen. Study results from the Breast Cancer Prevention Trial show that tamoxifen can reduce the likelihood of developing breast
Breast Cancer Prevention
by National Cancer Institute
Doctors cannot always explain why one person gets cancer and another does not. However, scientists have studied general patterns of cancer in the population to learn what things around us and what things we do in our lives may increase our chance
Breast Cancer and Pregnancy
by National Cancer Institute
Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. Breast cancer is sometimes detected (found) in women who are pregnant or have just given birth.
Breast Cancer Treatment
by National Cancer Institute
Different types of treatment are available for patients with breast cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials.
Stages of Breast Cancer
by National Cancer Institute
After breast cancer has been diagnosed, tests are done to find out if cancer cells have spread within the breast or to other parts of the body. The process used to find out whether the cancer has spread within the breast or to other parts of the body
| 